Understanding the Allergan Implant Recall

As our patients know firsthand, the safety and well-being of our patients are always at the heart of everything we do.

You may have heard that Allergan, the makers of many silicone breast implants, has recently issued a recall of one style of breast implant they provide. A recent publication provided by the U.S. Food and Drug Administration (FDA) detailed the uncommon incidence of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) and its relation to the Allergan textured breast implants. The recall specifically targets the BIOCELL® textured breast implants and tissue expanders.

Our practice does not use, nor has ever used, textured implants.

We have only ever used smooth, round breast implants, so this recall does not affect our patients. Still, Drs. Donaldson and Sieffert recognize this recall as an opportunity to help educate our community about illnesses related to breast implants and to put worrying minds at ease.

If you have any concerns over this recall, please note that the condition is treatable when it’s diagnosed and treated early by a medical professional. Scheduling an ultrasound as soon as possible is recommended; however, our patients should not be affected by this condition.

Watch our above video of plastic surgeons Dr. Donaldson and Dr. Sieffert discussing the recall and their recommendations for patients who may be worried about the possibility of developing BIA-ALCL.

About The Author

Jeffrey Donaldson, MD is a board-certified plastic surgeon with more than 20+ years of experience performing successful breast augmentations. He is incredibly meticulous when it comes to deciding which implants he uses – both from a safety and results-driven perspective. If you ever have any concerns about your breast implants or other cosmetic surgery procedures, contact the team at Donaldson Plastic Surgery & Aesthetic Solutions.